Abstract:277 Objectives The aim of this study is to employ a pretargeted approach that leverages the power of a supramolecular nanoparticle (SNP) vector and in vivo bioorthogonal chemistry for improved tumor PET imaging. Methods A reactive bioorthogonal motif (a trans-cyclooctene group, TCO) was encapsulated into an SNP vector (TCO-SNPs) constructed from adamantane-grafted polyamidoamine dendrimers, adamantane-functionalized polyethylene glycol, and β-cyclodextrin-grafted branched polyethylenimine. A complementary bioorthogonal motif (a tetrazine group, Tz) was radiolabeled with 18F to afford a radiolabeled reporter (18F-Tz). Transmission electron microscope (TEM) was used for directly examining the morphology and size of SNPs. Static microPET scans were performed at various time points after iv injection of 18F-Tz in U87MG glioblastoma mouse xenografts. Results The TEM measurements indicated that the size of SNPs was about 100 nm. The total synthesis time for 18F-Tz, including final high-performance liquid chromatography purification, was about 150 min. The decay-corrected radiochemical yield was 12±3% (n = 6). PET imaging results showed that the U87MG tumors can be clearly visualized as early as at 30 min postinjection of 18F-Tz, suggesting that the in vivo bioconjugation of TCO-grafted molecular building block and 18F-Tz was very rapid. Good tumor retention of radioactivity was observed from PET imaging. At 2 h pi, the tumor-to-muscle (T/M) ratio can reach 2.94±0.48. Ex vivo studies further confirmed the in vivo imaging findings. Conclusions We have demonstrated a new pretargeted approach to achieve improved tumor PET imaging. The new strategy decouples a tumor-targeting agent (such as nanoparticles) from a radiolabeled imaging agent, leading to a superb capability of optimizing the PKs of both nanoparticles and radiolabeled imaging agents to obtain optimal in vivo imaging performances. Research Support This work was supported by the USC Department of Radiology.

Bioorthogonal Nanosystem for Near-Infrared Fluorescence Imaging and Prodrug Activation in Mouse Model

Tetrazine-Mediated Bioorthogonal System for Prodrug Activation, Photothermal Therapy, and Optoacoustic Imaging

A Bioorthogonal Nanosystem for Imaging and in Vivo Tumor Inhibition.

Dual stimulus-triggered bioorthogonal nanosystem for spatiotemporally controlled prodrug activation and near-infrared fluorescence imaging

Bioorthogonally activatable cyanine dye with torsion-induced disaggregation for in vivo tumor imaging

Improved Tumor Targeting and Longer Retention Time of NIR Fluorescent Probes Using Bioorthogonal Chemistry.

Nanovoid-confinement and click-activated nanoreactor for synchronous delivery of prodrug pairs and precise photodynamic therapy

Coordinating Bioorthogonal Reactions with Two Tumor-Microenvironment-responsive Nanovehicles for Spatiotemporally Controlled Prodrug Activation

Pretargeted Approach for Tumor Pet Imaging Using Supramolecular Nanoparticles with in Vivo Bioorthogonal Chemistry

Enzyme‐Mediated in Situ Self‐Assembly Promotes in Vivo Bioorthogonal Reaction for Pretargeted Multimodality Imaging

In Vivo Bioorthogonal Labeling of Rare-Earth Doped Nanoparticles for Improved NIR-II Tumor Imaging by Extracellular Vesicle-Mediated Targeting

Intercellular delivery of bioorthogonal chemical receptors for enhanced tumor targeting and penetration

A High‐Efficiency Bioorthogonal Tumor‐Membrane Reactor for In Situ Selective and Sustained Prodrug Activation

On-Demand Activation of a Bioorthogonal Prodrug of SN-38 with Fast Reaction Kinetics and High Releasing Efficiency in Vivo

NIR-II light-activated and Cu nanocatalyst-enabled bioorthogonal reaction in living systems for efficient tumor therapy

"One-Stitch" Bioorthogonal Prodrug Activation Based on Cross-Linked Lipoic Acid Nanocapsules.

Controlled in Situ Self-Assembly of Biotinylated Trans-Cyclooctene Nanoparticles for Orthogonal Dual-Pretargeted Near-Infrared Fluorescence and Magnetic Resonance Imaging.

Redox-Activated Light-Up Nanomicelle for Precise Imaging-Guided Cancer Therapy and Real-Time Pharmacokinetic Monitoring

Enzymatic Non-Covalent Synthesis of a Versatile Platform for Bioorthogonal Prodrugs Activation to Combat Drug Resistance

An All-in-One Bioorthogonal System for Precise Cancer Therapy

Photocaged Prodrug under NIR Light-Triggering with Dual-Channel Fluorescence: in Vivo Real-Time Tracking for Precise Drug Delivery